199 related articles for article (PubMed ID: 33046090)
1. Early start of growth hormone is associated with positive effects on auxology and metabolism in Prader-Willi-syndrome.
Magill L; Laemmer C; Woelfle J; Fimmers R; Gohlke B
Orphanet J Rare Dis; 2020 Oct; 15(1):283. PubMed ID: 33046090
[TBL] [Abstract][Full Text] [Related]
2. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
[TBL] [Abstract][Full Text] [Related]
3. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
4. [Changes in carbohydrate metabolism and insulin resistance in patients with Prader-Willi Syndrome (PWS) under growth hormone therapy].
Lämmer C; Weimann E
Wien Med Wochenschr; 2007 Feb; 157(3-4):82-8. PubMed ID: 17340066
[TBL] [Abstract][Full Text] [Related]
5. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
[TBL] [Abstract][Full Text] [Related]
6. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
[TBL] [Abstract][Full Text] [Related]
8. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.
Carrel AL; Myers SE; Whitman BY; Eickhoff J; Allen DB
J Clin Endocrinol Metab; 2010 Mar; 95(3):1131-6. PubMed ID: 20061431
[TBL] [Abstract][Full Text] [Related]
9. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
[TBL] [Abstract][Full Text] [Related]
10. Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome.
Dykens EM; Roof E; Hunt-Hawkins H
J Child Psychol Psychiatry; 2017 Jan; 58(1):64-74. PubMed ID: 27481444
[TBL] [Abstract][Full Text] [Related]
11. Effects of early recombinant human growth hormone treatment in young Chinese children with Prader-Willi syndrome.
Gao Y; Yang LL; Dai YL; Shen Z; Zhou Q; Zou CC
Orphanet J Rare Dis; 2023 Feb; 18(1):25. PubMed ID: 36750945
[TBL] [Abstract][Full Text] [Related]
12. 25OH vitamin D levels in pediatric patients affected by Prader-Willi syndrome.
Fintini D; Pedicelli S; Bocchini S; Bizzarri C; Grugni G; Cappa M; Crinò A
J Endocrinol Invest; 2018 Jun; 41(6):739-742. PubMed ID: 29101669
[TBL] [Abstract][Full Text] [Related]
13. Multicentric Italian case-control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome.
Panfili FM; Convertino A; Grugni G; Mazzitelli L; Bocchini S; Crinò A; Campana G; Cappa M; Delvecchio M; Faienza MF; Licenziati MR; Mariani M; Osimani S; Pajno R; Patti G; Rutigliano I; Sacco M; Scarano E; Fintini D;
J Endocrinol Invest; 2023 Jul; 46(7):1397-1406. PubMed ID: 36708456
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
Grugni G; Marzullo P
Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
[TBL] [Abstract][Full Text] [Related]
15. Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition.
Damen L; Donze SH; Kuppens RJ; Bakker NE; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
Orphanet J Rare Dis; 2020 Jun; 15(1):163. PubMed ID: 32580778
[TBL] [Abstract][Full Text] [Related]
16. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
Eiholzer U; Meinhardt U; Gallo C; Schlumpf M; Rousson V; l'Allemand D
J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
[TBL] [Abstract][Full Text] [Related]
17. Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study.
Jørgensen AP; Ueland T; Sode-Carlsen R; Schreiner T; Rabben KF; Farholt S; Høybye C; Christiansen JS; Bollerslev J
Growth Horm IGF Res; 2014 Feb; 24(1):16-21. PubMed ID: 24360789
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
19. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
